Tseng 2015

Submitted by Q-Crew-Admin on Wednesday June 15 2016

WILLIAM W. TSENG, MD
University of Southern California
Immune Profiling in Well Differentiated/Dedifferentiated Liposarcoma

Pages

Where can I find a sarcoma specialist?

View locations
Financial Contributions

Donate, Sponsor, Support

New study in Ewing Sarcoma open to enrollment

SARC037 IS OPEN FOR ACCRUAL
SARC037 is a phase I study protocol to determine the recommended dose of trabectedin given as a 1-hour infusion in combination with low dose irinotecan. All patients enrolled will receive trabectedin combination with low does irinotecan.

Read more here

See all news items

MEET THE PEOPLE OF SARC

Erin Peregrine Antalis, Research Manager
Erin Peregrine Antalis joined SARC in May 2019 as Research Manager. Erin earned her PhD in Anthropology and Masters of Public Health from the University of Illinois at Chicago.

Read full bio

See all bios

Subscribe to SARC RSS